Sensorium Therapeutics Funding: $56M Raised, Series A (2025)

Sensorium Therapeutics funding overview

Sensorium Therapeutics is a Biotech company based in Boston. Sensorium Therapeutics has raised $56M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in August 2025. The round record for Sensorium Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Santé··Ventures, Route 66 Capital, CU Innovation Fund, Dolby Family Ventures, Hatteras Venture Partners, Mission Biocapital and 7 others. 13 distinct backers are named across the disclosed rounds.

Sensorium Therapeutics at a glance

Total raised

$56M

Latest round

Series A

Latest round date

August 2025

Industry

Biotech

Headquarters

Boston

Notable investors

Santé··Ventures, Route 66 Capital, CU Innovation Fund, Dolby Family Ventures, Hatteras Venture Partners, Mission Biocapital, Mockingbird Credit Partners, WPSS.bio

Frequently asked about Sensorium Therapeutics funding

How much has Sensorium Therapeutics raised?

Sensorium Therapeutics has raised $56M in total disclosed funding across the rounds on record.

Who has invested in Sensorium Therapeutics?

Santé··Ventures, Route 66 Capital, CU Innovation Fund, Dolby Family Ventures, Hatteras Venture Partners, Mission Biocapital are named among the investors backing Sensorium Therapeutics.

What was the latest Sensorium Therapeutics funding round?

The most recent disclosed round is a Series A, announced in August 2025.

Where is Sensorium Therapeutics based?

Sensorium Therapeutics is based in Boston.

What sector does Sensorium Therapeutics operate in?

Sensorium Therapeutics is tracked under Biotech from Boston, with $56M in disclosed funding.

When did Sensorium Therapeutics last raise?

The last disclosed Sensorium Therapeutics round closed in August 2025 at Series A.

We update the Sensorium Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Boston and their backers are listed below.

Sensorium Therapeutics funding history

3 disclosed rounds on record, including 2 reported through SEC Form D filings.

1. August 2025 — Series A. $25M.
2. Filed February 2025 — Private financing. $26.8M sold of a $58.5M offering. 19 investors reported. SEC Form D filing
3. Filed December 2023 — Private financing. $24.7M sold of a $24.8M offering. 64 investors reported. SEC Form D filing

SEC Form D filings report the amount sold against a stated offering size, which can differ from press-reported round totals, and they do not name the round — those entries appear as Private financing.

Companies related to Sensorium Therapeutics (35)

• Solu Therapeutics
• ABK Biomedical
• Metsera
• Revolution Medicines
• Kailera Therapeutics
• Neuralink
• Kriya Therapeutics
• Treeline Biosciences
• 23andMe
• Beam Therapeutics
• Xaira Therapeutics
• Oruka Therapeutics
• ORIC Pharmaceuticals
• Recursion Pharmaceuticals
• Generate Biomedicines
• Odyssey Therapeutics
• Astria Therapeutics
• MapLight Therapeutics
• NewLimit
• Mirador Therapeutics
• Dana-Farber Cancer Institute
• Plymouth Industrial REIT
• Klaviyo
• Nexamp
• Rhythm Pharmaceuticals
• Thrasio
• Thumbtack
• Perch
• Lendbuzz
• Ginkgo Bioworks
• Aura Company
• Nimbus Therapeutics
• WHOOP
• Coralogix
• Toast

Browse related funding lists (8)

• Series A stage companies
• Startups in Boston
• Investors in Boston
• Companies that raised 50m 100m
• Companies funded in 2025
• Companies backed by Dolby Family Ventures
• Companies backed by Hatteras Venture Partners
• Companies backed by Mission Biocapital

Company funding database · Investor directory · Founder database · Mega-rounds 2026